Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 2 » Issue 3

Factors affecting health status in COPD patients with co-morbid anxiety or depression

Authors Minna J Hynninen, Ståle Pallesen, Inger Hilde Nordhus

Published Date October 2007 Volume 2007:2(3) Pages 323—328

DOI

Published 9 October 2007

Minna J Hynninen¹, Ståle Pallesen², Inger Hilde Nordhus¹

¹Department of Clinical Psychology, University of Bergen, Norway ²Department of Psychosocial Science, University of Bergen, Norway

Abstract: Health status questionnaires provide standardized measures of patients’ perceptions of the impact of disease on their daily life and well-being. Factors associated with health status were examined in a sample of 58 outpatients with chronic obstructive pulmonary disease (COPD) and co-morbid anxiety and/or depression. A cross-sectional descriptive study was conducted with the following measures: The St. George’s Respiratory Questionnaire (SGRQ); the Beck Anxiety Inventory (BAI); the Beck Depression Inventory, 2nd edition (BDI); the Pittsburgh Sleep Quality Index (PSQI); and spirometry. Disease severity as measured with spirometry was not related to health status. Perceptions of poor health as implied by the health status scores were positively associated with symptoms of anxiety and depression, sleep disturbances, and level of daily functioning. There were statistically significant differences between men and women on COPD severity, age, and the BAI scores. The findings emphasize the importance of screening the patients at all stages of disease severity for anxiety, depression, and sleeping problems, in order to provide adequate care for these problems.

Keywords: COPD, health status, health-related quality of life, anxiety, depression, sleep

Download Article [PDF] 

Readers of this article also read:

Red cell distribution width and neurological scoring systems in acute stroke patients

Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru A, Akyurek F, Kayis SA

Neuropsychiatric Disease and Treatment 2015, 11:733-739

Published Date: 18 March 2015

Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging

Li D, Tang X, Pulli B, Lin C, Zhao P, Cheng J, Lv Z, Yuan X, Luo Q, Cai H, Ye M

International Journal of Nanomedicine 2014, 9:3347-3361

Published Date: 10 July 2014

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment

Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L

International Journal of Nanomedicine 2011, 6:2429-2435

Published Date: 19 October 2011

Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system

Estevanato L, Cintra D, Baldini N, Portilho F, Barbosa L, Martins O, Lacava B, Miranda-Vilela AL, Tedesco AC, Báo S, Morais PC, Lacava ZGM

International Journal of Nanomedicine 2011, 6:1709-1717

Published Date: 18 August 2011

Physician contact by older Asian Americans: the effects of perceived mental health need

Duy Nguyen

Clinical Interventions in Aging 2010, 5:333-336

Published Date: 16 November 2010

Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease

Felix C Ringshausen, Ai-Yui M Tan, Tobias Allander, Irmgard Borg, Umut Arinir, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:111-117

Published Date: 4 February 2009

Hyaluronic acid gel (Juvéderm™) preparations in the treatment of facial wrinkles and folds

Inja Bogdan Allemann, Leslie Baumann

Clinical Interventions in Aging 2008, 3:629-634

Published Date: 22 January 2009

Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease

Chiara Bellia, Giulia Bivona, Concetta Scazzone, Marcello Ciaccio

Therapeutics and Clinical Risk Management 2007, 3:999-1001

Published Date: 17 January 2007